# 180 Life Sciences Corp. (ATNF)

Source: https://www.quantisnow.com/company/ATNF
Generated: 2026-11-10T12:31:39.220Z

- Ticker: ATNF
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2017
- Website: 180lifesciences.com

## About

180 Life Sciences Corp., a clinical-stage biotechnology company, engages in the development of drug candidates in the areas of inflammatory diseases, fibrosis, and pain. Its product development platforms in Phase IIb/III clinical trials include Fibrosis and Anti-TNF platform, which focuses on fibrosis and anti-tumor necrosis factors; Synthetic Cannabidiol (CBD) Analogs platform, which are man-made derivatives of CBD; and a7nAChR platform, which focuses on alpha 7 nicotinic acetylcholine receptor. The company is headquartered in Menlo Park, California.

## Latest ATNF news and filings

- 2025-08-26 21:20 UTC [SEC Form PRE 14A] [SEC Form PRE 14A filed by 180 Life Sciences Corp.](https://www.quantisnow.com/insight/sec-form-pre-14a-filed-by-180-life-sciences-corp-6179578)
- 2025-08-25 22:53 UTC [SEC Form 4] [Chief Executive Officer Jordan Blair disposed of 200,000 shares (SEC Form 4)](https://www.quantisnow.com/insight/chief-executive-officer-jordan-blair-disposed-of-200000-shares-sec-6178247)
- 2025-08-25 12:00 UTC [SEC Form 8-K] [180 Life Sciences Corp. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/180-life-sciences-corp-filed-sec-form-8-k-regulation-fd-6177084)
- 2025-08-22 23:12 UTC [SEC Form 8-K] [180 Life Sciences Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits](https://www.quantisnow.com/insight/180-life-sciences-corp-filed-sec-form-8-k-entry-into-6176852)
- 2025-08-22 21:20 UTC [SEC Form 424B5] [SEC Form 424B5 filed by 180 Life Sciences Corp.](https://www.quantisnow.com/insight/sec-form-424b5-filed-by-180-life-sciences-corp-6176600)
- 2025-08-22 20:49 UTC [SEC Form S-3ASR] [SEC Form S-3ASR filed by 180 Life Sciences Corp.](https://www.quantisnow.com/insight/sec-form-s-3asr-filed-by-180-life-sciences-corp-6176429)
- 2025-08-22 11:58 UTC [SEC Form S-3ASR] [SEC Form S-3ASR filed by 180 Life Sciences Corp.](https://www.quantisnow.com/insight/sec-form-s-3asr-filed-by-180-life-sciences-corp-6175627)
- 2025-08-22 11:55 UTC [SEC Form S-3ASR] [SEC Form S-3ASR filed by 180 Life Sciences Corp.](https://www.quantisnow.com/insight/sec-form-s-3asr-filed-by-180-life-sciences-corp-6175619)
- 2025-08-20 23:30 UTC [SEC Form 8-K] [180 Life Sciences Corp. filed SEC Form 8-K: Unregistered Sales of Equity Securities](https://www.quantisnow.com/insight/180-life-sciences-corp-filed-sec-form-8-k-unregistered-sales-6174144)
- 2025-08-20 23:32 UTC [SEC Form 8-K] [Amendment: 180 Life Sciences Corp. filed SEC Form 8-K: Unregistered Sales of Equity Securities, Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Leadership Update, Material Modification to Rights of Security Holders, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/amendment-180-life-sciences-corp-filed-sec-form-8-k-unregistered-6174141)
- 2025-08-18 21:27 UTC [SEC Form 4] [Former 10% Owner Elray Resources, Inc. sold $9,278,586 worth of shares (2,998,000 units at $3.09) and exercised 3,000,000 in-the-money shares at a strike of $1.68, increasing direct ownership by 0.15% to 1,320,000 units (SEC Form 4)](https://www.quantisnow.com/insight/former-10-owner-elray-resources-inc-sold-9278586-worth-of-6170512)
- 2025-08-18 21:22 UTC [Amendment: SEC Form SCHEDULE 13D/A filed by 180 Life Sciences Corp.](https://www.quantisnow.com/insight/amendment-sec-form-schedule-13da-filed-by-180-life-sciences-6170493)
- 2025-08-18 12:01 UTC [SEC Form 8-K] [180 Life Sciences Corp. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/180-life-sciences-corp-filed-sec-form-8-k-regulation-fd-6169386)
- 2025-08-18 12:00 UTC [ETHZilla Unveils New Brand Committed to Advancing Ethereum Treasury Strategy](https://www.quantisnow.com/insight/ethzilla-unveils-new-brand-committed-to-advancing-ethereum-treasury-strategy-6169373)
- 2025-08-18 10:33 UTC [SEC Form 8-K] [Amendment: 180 Life Sciences Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/amendment-180-life-sciences-corp-filed-sec-form-8-k-entry-6169218)
- 2025-08-14 20:33 UTC [SEC Form 144] [SEC Form 144 filed by 180 Life Sciences Corp.](https://www.quantisnow.com/insight/sec-form-144-filed-by-180-life-sciences-corp-6166655)
- 2025-08-14 01:29 UTC [SEC Form 424B5] [SEC Form 424B5 filed by 180 Life Sciences Corp.](https://www.quantisnow.com/insight/sec-form-424b5-filed-by-180-life-sciences-corp-6164147)
- 2025-08-14 01:29 UTC [SEC Form 8-K] [180 Life Sciences Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits](https://www.quantisnow.com/insight/180-life-sciences-corp-filed-sec-form-8-k-entry-into-6164146)
- 2025-08-13 20:26 UTC [SEC Form 8-K] [180 Life Sciences Corp. filed SEC Form 8-K: Unregistered Sales of Equity Securities, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/180-life-sciences-corp-filed-sec-form-8-k-unregistered-sales-6163369)
- 2025-08-12 21:20 UTC [SEC Form 4] [SEC Form 4 filed by Executive Chairman Rudisill Mcandrew](https://www.quantisnow.com/insight/sec-form-4-filed-by-executive-chairman-rudisill-mcandrew-6161395)
- 2025-08-12 20:15 UTC [SEC Form 3] [SEC Form 3 filed by new insider Heter Crystal Jane](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-heter-crystal-jane-6160764)
- 2025-08-12 17:00 UTC [SEC Form SCHEDULE 13G filed by 180 Life Sciences Corp.](https://www.quantisnow.com/insight/sec-form-schedule-13g-filed-by-180-life-sciences-corp-6160213)
- 2025-08-12 12:01 UTC [SEC Form 8-K] [180 Life Sciences Corp. filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/180-life-sciences-corp-filed-sec-form-8-k-regulation-fd-6159733)
- 2025-08-12 12:00 UTC [180 Life Sciences (ETHZilla) Holds 82,186 ETH](https://www.quantisnow.com/insight/180-life-sciences-ethzilla-holds-82186-eth-6159715)
- 2025-08-11 23:48 UTC [SEC Form 4] [SEC Form 4 filed by Director Shoemaker Stephen H](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-shoemaker-stephen-h-6159213)
- 2025-08-11 23:35 UTC [SEC Form 4] [SEC Form 4 filed by Director Smith Ryan Lewis](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-smith-ryan-lewis-6159209)
- 2025-08-11 23:30 UTC [SEC Form 4] [SEC Form 4 filed by Chief Executive Officer Jordan Blair](https://www.quantisnow.com/insight/sec-form-4-filed-by-chief-executive-officer-jordan-blair-6159207)
- 2025-08-11 14:03 UTC [SEC Form 8-K] [180 Life Sciences Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Leadership Update, Material Modification to Rights of Security Holders, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/180-life-sciences-corp-filed-sec-form-8-k-entry-into-6157857)
- 2025-08-11 12:00 UTC [Public Offering] [180 Life Sciences Announces Closing of Private Offering of Approximately $156 Million of Convertible Notes](https://www.quantisnow.com/insight/180-life-sciences-announces-closing-of-private-offering-of-approximately-6157539)
- 2025-08-07 20:25 UTC [SEC Form 3] [SEC Form 3 filed by new insider Suckling Andrew P](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-suckling-andrew-p-6154214)
- 2025-08-07 20:20 UTC [SEC Form 3] [New insider Rudisill Mcandrew claimed ownership of 566,035 shares (SEC Form 3)](https://www.quantisnow.com/insight/new-insider-rudisill-mcandrew-claimed-ownership-of-566035-shares-sec-6153984)
- 2025-08-07 20:19 UTC [SEC Form 144] [SEC Form 144 filed by 180 Life Sciences Corp.](https://www.quantisnow.com/insight/sec-form-144-filed-by-180-life-sciences-corp-6153940)
- 2025-08-07 20:15 UTC [SEC Form 4] [SEC Form 4 filed by Director Shoemaker Stephen H](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-shoemaker-stephen-h-6153874)
- 2025-08-07 00:49 UTC [SEC Form 4] [SEC Form 4 filed by Director Smith Ryan Lewis](https://www.quantisnow.com/insight/sec-form-4-filed-by-director-smith-ryan-lewis-6151718)
- 2025-08-07 00:28 UTC [SEC Form 4] [SEC Form 4 filed by Chief Executive Officer Jordan Blair](https://www.quantisnow.com/insight/sec-form-4-filed-by-chief-executive-officer-jordan-blair-6151700)
- 2025-08-05 20:04 UTC [SEC Form 8-K] [180 Life Sciences Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Other Events, Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/180-life-sciences-corp-filed-sec-form-8-k-entry-into-6147202)
- 2025-08-05 02:30 UTC [Leadership Update] [180 Life Sciences Closes $425 Million Private Placement to Advance its Ethereum Treasury Strategy](https://www.quantisnow.com/insight/180-life-sciences-closes-425-million-private-placement-to-advance-6145782)
- 2025-07-30 10:28 UTC [SEC Form 8-K] [180 Life Sciences Corp. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Leadership Update, Changes in Control of Registrant, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/180-life-sciences-corp-filed-sec-form-8-k-entry-into-6137470)
- 2025-07-29 13:26 UTC [Conference Announcement] [180 Life Sciences Announce an Upsized $425 Million Private Placement to Establish an Ether Treasury Reserve Led by Consortium of Digital Asset Leaders to Launch ETHZilla](https://www.quantisnow.com/insight/180-life-sciences-announce-an-upsized-425-million-private-placement-6135732)
- 2025-07-24 21:08 UTC [SEC Form S-8] [SEC Form S-8 filed by 180 Life Sciences Corp.](https://www.quantisnow.com/insight/sec-form-s-8-filed-by-180-life-sciences-corp-6132073)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/ATNF
- Earnings history: https://www.quantisnow.com/earnings/ATNF
- Dividend history: https://www.quantisnow.com/dividends/ATNF
- Insider transactions: https://www.quantisnow.com/insiders/ATNF
- Options chain: https://www.quantisnow.com/options/ATNF
- SEC 8-K filings only: https://www.quantisnow.com/company/ATNF/8-k
- RSS and alerts for ATNF: https://www.quantisnow.com/docs/rss-feeds.md